BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30929335)

  • 1. [Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].
    Li J; Guo ZX; Chen JA; Xue C; Sun LL; Ren ZG; Li A; Cui GY; Yu ZJ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):192-197. PubMed ID: 30929335
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
    Qin AD; Liu XX; Li J; Liu J; Li YS
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormal expression of insulin-like growth factor-I receptor and inhibitory effect of its transcription intervention on nude mice xenograft tumor].
    Yao M; Yan XD; Cai Y; Gu JJ; Yang XL; Pan LH; Wang L; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):846-851. PubMed ID: 27978931
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway.
    Zhang MX; Xu XM; Zhang P; Han NN; Deng JJ; Yu TT; Gan YY; He XQ; Long ZX
    Tumour Biol; 2016 Feb; 37(2):2023-35. PubMed ID: 26337275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q; Cai W; Zhang M; Liu Q; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of CAAP1 on Proliferation, Migration and Invasion of Hepatoma Cell Line SMMC-7721].
    Su JH; Lu HJ; Wang YT; Kong YX; Liu YT; Wang MM; Xiong YN; Zhang GL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):445-451. PubMed ID: 34018363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth inhibition of human hepatocellular carcinoma by miRNA-204 via down-regulation of Bcl-2 and Sirt1 expression].
    Li K; Xyu Q; Liu X; Liu Q; Wang M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):168-72. PubMed ID: 25652855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
    Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
    Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression and significance of chromobox protein homolog 2 in breast cancer].
    Guo XH; Zhang JY; Jiao DC; Zhu JJ; Ma YZ; Yang Y; Xiao H; Liu ZZ
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(2):130-135. PubMed ID: 31937053
    [No Abstract]   [Full Text] [Related]  

  • 14. The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma.
    Li H; Fang L; Xiao X; Shen L
    Bull Cancer; 2012 Mar; 99(3):E26-33. PubMed ID: 22285430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
    Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEK2 promotes the progression of liver cancer by resisting the cellular senescence.
    Lei Q; Xia J; Feng X; Guo J; Li G; Zhou W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):153-164. PubMed ID: 35545405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of mucin 15 in hepatocellular carcinoma and its clinical implications].
    Liu Q; Tian Q; Zhang H; Zheng X; Yao Y; Liu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Nov; 34(11):1611-5. PubMed ID: 25413059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of miR-218 in human hepatocellular carcinoma and its role in cell growth.
    Tu K; Li C; Zheng X; Yang W; Yao Y; Liu Q
    Oncol Rep; 2014 Oct; 32(4):1571-7. PubMed ID: 25110121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
    Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
    Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.